Core Viewpoint - The stock of iFlytek Medical Technology (02506) has risen over 10%, currently trading at 89 HKD with a transaction volume of 53.99 million HKD, following the launch of OpenAI's ChatGPT Health feature, which is similar to Ant Group's AI health assistant, "Antifufu" [1] Group 1: Company Developments - On January 8, OpenAI launched the ChatGPT Health feature, designed to answer health-related questions, connect smart devices, and plan diet and exercise, indicating a competitive landscape in AI health solutions [1] - Ant Group's AI health assistant, "Antifufu," has been rebranded and connects to 5,000 hospitals and 300,000 real doctors for online consultations, showcasing the integration of AI in healthcare [1] - iFlytek Medical Technology is set to release the "iFlytek Spark Medical Model X1" based on deep reasoning technology in March 2025, which is the only medical deep reasoning model trained entirely on domestic computing power [1] Group 2: Performance Metrics - In real-world testing, the general diagnostic assistance accuracy of the iFlytek model reached 94.0%, indicating high performance in practical applications [1] - The iFlytek Spark Medical Model underwent capability upgrades in July 2025, with multiple performance indicators further improved, reflecting ongoing advancements in AI healthcare technology [1] - Southwest Securities believes that AI in healthcare is a clear policy growth direction, and the company, as a leader in the field, stands to benefit significantly [1]
讯飞医疗科技涨超10% OpenAI发布ChatGPT Health 公司有望充分受益AI医疗发展